oxycodone has been researched along with methylphenidate in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Okon, T | 1 |
Carter, LP; Haddox, JD; Henningfield, JE; Johnson, RE; Lindholm, A; McCormick, CG; Rosen, S; Seeger, V; Varughese, S; Waxman, D; Wissel, J | 1 |
Backman, E; Höjer, J; Jonsson, B; Salmonson, H | 1 |
2 review(s) available for oxycodone and methylphenidate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Ketamine: an introduction for the pain and palliative medicine physician.
Topics: Adult; Amines; Analgesics; Analgesics, Opioid; Central Nervous System; Cryoglobulinemia; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hepatitis C; Humans; Ketamine; Methadone; Methylphenidate; Oxycodone; Pain, Intractable; Receptors, N-Methyl-D-Aspartate; Treatment Outcome; Ulcer; Vasculitis | 2007 |
5 other study(ies) available for oxycodone and methylphenidate
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
'Black box' drug warnings.
Topics: Albuterol; Androstadienes; Drug Labeling; Estrogens; Fentanyl; Humans; Methylphenidate; Oxycodone; Thyroxine | 2004 |
Case histories in pharmaceutical risk management.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Dextroamphetamine; Drug and Narcotic Control; Drug Industry; History, 20th Century; History, 21st Century; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Naloxone; Oxycodone; Product Surveillance, Postmarketing; Risk Management; Sodium Oxybate; Substance-Related Disorders | 2009 |
Injection of crushed tablets--a prospective observational study.
Topics: Adolescent; Adult; Azabicyclo Compounds; Benzodiazepines; Buprenorphine; C-Reactive Protein; Female; gamma-Aminobutyric Acid; Humans; Injections, Intravenous; Male; Methylphenidate; Morphine; Oxycodone; Piperazines; Poison Control Centers; Pregabalin; Prospective Studies; Substance-Related Disorders; Sweden; Tablets; Young Adult | 2014 |